
Dr. Neeraj Teotia
Consultant — Paediatric Hemato-Oncology and Bone Marrow Transplant
Paediatric Haematologist and Bone Marrow Transplant Specialist
295 verified reviews
295
Recent Consultations
About Dr. Neeraj Teotia
Dr. Neeraj Teotia is a Consultant in Paediatric Hemato-Oncology and Bone Marrow Transplant at Marengo Asia Hospitals, Gurugram, with over 10 years of specialized clinical experience. He holds an MBBS from JN Medical College, Belgaum, an MD in Paediatrics from LLRM Medical College, Meerut, and an FNB in Paediatric Haematology-Oncology from RGCIRC, Delhi. His expertise is further strengthened by a prestigious Fellowship in Pediatric Bone Marrow Transplant and Cellular Therapy from the Royal Bristol Hospital for Children and Bristol Haematology Oncology Centre, UHBW, Bristol, UK, where he trained in international best practices.
Dr. Teotia has successfully performed over 200 bone marrow transplants, encompassing autologous, allogeneic, matched unrelated donor, and haploidentical procedures. His clinical depth spans the full spectrum of pediatric hematologic malignancies and inherited disorders, including acute leukemia, thalassemia, aplastic anemia, and sickle cell disease in children. He brings meticulous attention to patient outcomes and employs evidence-based protocols refined through his international training.
He actively treats pediatric patients from across the Middle East, Gulf countries, and Africa, and is experienced in supporting international families through the complexities of bone marrow transplantation. His multilingual capability in English and Hindi facilitates clear communication with patients and caregivers from diverse backgrounds. Dr. Teotia understands the emotional and logistical challenges families face when seeking specialized pediatric oncology care abroad, and he provides comprehensive pre- and post-transplant guidance.
At Marengo Asia Hospitals, Gurugram, Dr. Teotia has access to state-of-the-art facilities, dedicated pediatric hematology-oncology units, and multidisciplinary team support. The hospital is recognized for its commitment to pediatric care and maintains rigorous infection control and supportive care protocols essential for transplant patients. International patients benefit from organized medical tourism assistance, quality accommodation guidance, and streamlined coordination with the hospital's international patient department.
Dr. Teotia is an active member of the European Society for Blood and Marrow Transplantation (EBMT), the Indian Society of Hematology and Blood Transfusion (ISHBT), and the Indian Academy of Pediatrics (IAP). He has over 10 publications in national and international journals, demonstrating his commitment to advancing pediatric transplant science. For families seeking expert bone marrow transplant care for a child in India, Dr. Teotia's internationally-trained expertise and access to modern hospital infrastructure make Gurugram an accessible and evidence-based destination.
Conditions Treated by Dr. Neeraj Teotia
- Acute Leukemia in Children
- Pediatric Lymphoma
- Pediatric Thalassemia Major
- Pediatric Aplastic Anemia
- Pediatric Sickle Cell Disease
- Severe Combined Immunodeficiency (SCID)
- Niemann-Pick Disease and Other Storage Disorders
- Primary Immune Deficiency Disorders
- High-Risk Pediatric Solid Tumors
- Hemophagocytic Lymphohistiocytosis
Areas of Interest
- Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Haploidentical Bone Marrow Transplant
- Matched Unrelated Donor Transplant
- Matched Sibling Donor Transplant
- Pediatric Leukemia
- Acute Leukemia
- Pediatric Thalassemia
- Pediatric Aplastic Anemia
- Pediatric Sickle Cell Disease
Qualifications
- MBBS — JN Medical College, Belgaum
- MD — LLRM Medical College, Meerut
- FNB — RGCIRC, Delhi
- Fellowship in Pediatric Bone Marrow Transplant & Cellular Therapy — Royal Bristol Hospital for Children and Bristol Haematology Oncology Centre, UHBW, Bristol, UK
Work Experience
- Consultant — Paediatric Hemato-Oncology and Bone Marrow Transplant, Marengo Asia Hospitals, Gurugram, Present
- Consultant — Paediatric Hemato-Oncology and Bone Marrow Transplant, Marengo Asia Hospitals, Faridabad, Present
- Senior Consultant — Pediatric Hematology-Oncology, Indraprastha Apollo Hospital, Delhi (former)
- Faculty and Attending Physician, Rajiv Gandhi Cancer Institute and Research Centre, Delhi (former)
- Senior Resident and Fellow, Royal Bristol Hospital for Children, Bristol, UK (former)
- Faculty, UCMS Delhi (former)
Certifications (4)
MBBS
JN Medical College, Belgaum
MD in Paediatrics
LLRM Medical College, Meerut
FNB in Paediatric Haematology-Oncology
RGCIRC, Delhi
Fellowship in Pediatric Bone Marrow Transplant & Cellular Therapy
Royal Bristol Hospital for Children and Bristol Haematology Oncology Centre, UHBW, Bristol, UK
Memberships (3)
- EBMT (European Society for Blood and Marrow Transplantation)
- ISHBT (Indian Society of Hematology and Blood Transfusion)
- IAP (Indian Academy of Pediatrics)
Research Papers & Publications (5)
Outcomes of Haploidentical Bone Marrow Transplantation in Pediatric Acute Leukemia: Single Centre Experience
Indian Journal of Hematology and Blood Transfusion —
Role of Conditioning Regimens in Pediatric Allogeneic Stem Cell Transplantation: A Review
Pediatric Blood and Cancer —
Immunological Recovery Following Pediatric Bone Marrow Transplantation in Thalassemia Major
Bone Marrow Transplantation —
Graft-Versus-Host Disease Prevention Strategies in Pediatric Haploidentical Transplants
Indian Journal of Pediatrics —
Long-Term Survival and Quality of Life in Children Undergoing Autologous Transplantation for Lymphoma
Journal of Pediatric Oncology —
Procedures
Frequently Asked Questions
International patients can book a consultation through Gaf Healthcare's medical tourism platform. You can request a video consultation, which Dr. Teotia offers to review your child's medical history and imaging. Contact us via WhatsApp or email to submit your child's medical documents, previous treatment records, and imaging studies. Our team will coordinate the timing and provide follow-up care guidance once a treatment plan is finalized.
